BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16082223)

  • 1. APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.
    Rogozin IB; Basu MK; Jordan IK; Pavlov YI; Koonin EV
    Cell Cycle; 2005 Sep; 4(9):1281-5. PubMed ID: 16082223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of cytidine deaminases.
    Navaratnam N; Sarwar R
    Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
    Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
    J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
    Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
    Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast.
    Lada AG; Krick CF; Kozmin SG; Mayorov VI; Karpova TS; Rogozin IB; Pavlov YI
    Biochemistry (Mosc); 2011 Jan; 76(1):131-46. PubMed ID: 21568845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA deamination in immunity: AID in the context of its APOBEC relatives.
    Conticello SG; Langlois MA; Yang Z; Neuberger MS
    Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
    Severi F; Chicca A; Conticello SG
    Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vertebrate immunity: mutator proteins and their evolution].
    Lada AG; Iyer LM; Rogozin IB; Aravind L; Pavlov IuI
    Genetika; 2007 Oct; 43(10):1311-27. PubMed ID: 18069336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
    Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
    Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase.
    Anant S; Yu H; Davidson NO
    Biol Chem; 1998; 379(8-9):1075-81. PubMed ID: 9792440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral restriction by APOBEC proteins.
    Harris RS; Liddament MT
    Nat Rev Immunol; 2004 Nov; 4(11):868-77. PubMed ID: 15516966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity.
    Anant S; Martin SA; Yu H; MacGinnitie AJ; Devaney E; Davidson NO
    Mol Biochem Parasitol; 1997 Sep; 88(1-2):105-14. PubMed ID: 9274872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
    Jarmuz A; Chester A; Bayliss J; Gisbourne J; Dunham I; Scott J; Navaratnam N
    Genomics; 2002 Mar; 79(3):285-96. PubMed ID: 11863358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.
    Wedekind JE; Dance GS; Sowden MP; Smith HC
    Trends Genet; 2003 Apr; 19(4):207-16. PubMed ID: 12683974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice deficient in APOBEC2 and APOBEC3.
    Mikl MC; Watt IN; Lu M; Reik W; Davies SL; Neuberger MS; Rada C
    Mol Cell Biol; 2005 Aug; 25(16):7270-7. PubMed ID: 16055735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBECs and virus restriction.
    Harris RS; Dudley JP
    Virology; 2015 May; 479-480():131-45. PubMed ID: 25818029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviruses under editing crossfire: a second member of the human APOBEC3 family is a Vif-blockable innate antiretroviral factor.
    Trono D
    EMBO Rep; 2004 Jul; 5(7):679-80. PubMed ID: 15229643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.